The Philippine Heart Center has reached a significant milestone by successfully performing six Transcatheter Aortic Valve ...

Adding Farxiga (dapagliflozin) to standard care significantly reduced the risk of death or worsening heart failure in older ...

Zydus MedTech gets rights to market the innovative Transcatheter Aortic Valve Implantation technology in India, Europe and ...

The “passive” notification led to more patients with severe AS undergoing valve replacement, but more can be done still.

Zydus MedTech Private Limited, a wholly owned subsidiary of Zydus Lifesciences Limited on Friday entered into a strategic partnership with Braile Biomédica Indústria, Comércio e Representações Ltda., ...

The Philippine Heart Center has reached a significant milestone by successfully performing six Transcatheter Aortic Valve Implantation (TAVI) ...

Zydus MedTech collaborates with Braile Biomedica to commercialize TAVI technology across Europe, India, and other key markets ...

For over a decade, the McGill University Health Centre (MUHC) has been at the forefront of aortic valve innovation, advancing ...

Dapagliflozin reduced the risk of death or worsening heart failure in older patients with aortic stenosis who underwent transcatheter aortic-valve implantation.

A device in clinical development appears to be far safer and more effective than the TAVI devices currently being used ...

THE primary purpose of this report is to emphasize the relation of a high-pitched "squeaking" or "musical" systolic murmur to aortic stenosis and calcification of the aortic valve. This is not so ...